Clean Energy Health

Alternative Health + Wellness News, Products & Services
FDA Warns of Problems for Some Taking Hep C Drugs

liver anatomy illustration

Taking the hepatitis C drugs Mavyret, Zepatier or Vosevi can trigger rare cases of severe liver problems or liver failure in patients who already have moderate-to-severe liver impairment, the FDA warned Wednesday.

Leave comment

Your email address will not be published. Required fields are marked with *.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: